DIGESTIVE CANCER
Clinical trials for DIGESTIVE CANCER explained in plain language.
Never miss a new study
Get alerted when new DIGESTIVE CANCER trials appear
Sign up with your email to follow new studies for DIGESTIVE CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New drug shows promise against Hard-to-Treat digestive cancers
Disease control CompletedThis study tested an experimental drug called RC108 in 29 adults with advanced digestive system cancers that have a specific protein (c-Met). The goal was to see if the drug could shrink tumors or stop them from growing. Researchers also monitored side effects. The study is compl…
Matched conditions: DIGESTIVE CANCER
Phase: PHASE2 • Sponsor: RemeGen Co., Ltd. • Aim: Disease control
Last updated May 26, 2026 03:04 UTC
-
New drug cocktail shows promise for tough bile duct cancer
Disease control CompletedThis study tested a combination of the targeted drug regorafenib and chemotherapy (mGEMOX) in 66 people with advanced biliary tract cancer that could not be removed by surgery. The goal was to find the safest dose and see if the combo helps control the cancer. The trial focused o…
Matched conditions: DIGESTIVE CANCER
Phase: PHASE1, PHASE2 • Sponsor: Institut du Cancer de Montpellier - Val d'Aurelle • Aim: Disease control
Last updated May 18, 2026 12:12 UTC
-
Smartphone checkups could cut chemo waste, study finds
Knowledge-focused CompletedThis study tested whether asking patients with digestive cancer to report their symptoms online could give doctors enough information to decide if chemotherapy should be prepared, instead of requiring an in-person exam. 138 patients participated. The goal was to reduce the number…
Matched conditions: DIGESTIVE CANCER
Phase: NA • Sponsor: Centre Hospitalier Universitaire de Nīmes • Aim: Knowledge-focused
Last updated May 26, 2026 03:19 UTC